Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)

NCT02115321 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Grazoprevir
DRUG: Elbasvir
DRUG: MK-5172A

Sponsor

Merck Sharp & Dohme LLC